Suppr超能文献

盐替代对骨折的影响——盐替代与卒中研究(SSaSS)的二次分析。

Effect of salt substitution on fracture-a secondary analysis of the Salt Substitute and Stroke Study (SSaSS).

机构信息

School of Public Health, Ningxia Medical University, Yinchuan, Ningxia, China.

NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, Ningxia, China.

出版信息

BMC Med. 2024 Sep 4;22(1):366. doi: 10.1186/s12916-024-03586-7.

Abstract

BACKGROUND

Associations of dietary sodium and potassium intake with fracture risk are inconsistent and the effects of salt substitute on fracture incidence are unknown. We assessed the effect of salt substitute compared to regular salt intake on fracture incidence using data from the Salt Substitute and Stroke Study (SSaSS).

METHODS

SSaSS was a cluster-randomized controlled trial conducted in 600 villages in northern China. Villages were randomly allocated into intervention and control groups in a 1:1 ratio. Salt substitute was provided to intervention villages and control villages continued regular salt use for 5 years. The primary outcome for this secondary analysis was the incidence of all fractures. Secondary outcomes included incidence of vertebral fracture, non-vertebral fracture, and fracture of unknown or non-specific location.

RESULTS

20,995 participants were included in this study, and 821 fractures occurred during follow-up. Intention-to-treat analyses showed no differences between the salt substitute and regular salt groups in the incidence of all fractures (rate ratio (RR) 0.96; 95% CI 0.81 to 1.14), vertebral fracture (RR 0.82; 95% CI 0.53 to 1.26), non-vertebral fracture (RR 1.05; 95% CI 0.86 to 1.29), or fracture of unknown or non-specific location (RR 0.80; 95% CI 0.54 to 1.18).

CONCLUSIONS

Use of salt substitute compared to regular salt had no detectable effect on the incidence of fracture in a population at high risk of cardiovascular disease and fracture.

TRIAL REGISTRATION

ClinicalTrials.gov, NCT02092090. Registered on March 12, 2014.

摘要

背景

饮食钠和钾摄入量与骨折风险的关联并不一致,盐替代品对骨折发生率的影响也不清楚。我们使用来自盐替代与中风研究(SSaSS)的数据评估了盐替代品与常规盐摄入相比对骨折发生率的影响。

方法

SSaSS 是在中国北方 600 个村庄进行的一项集群随机对照试验。村庄以 1:1 的比例随机分为干预组和对照组。干预组提供盐替代品,对照组继续使用常规盐 5 年。本次二次分析的主要结局是所有骨折的发生率。次要结局包括椎体骨折、非椎体骨折和未知或非特定部位骨折的发生率。

结果

本研究共纳入 20995 名参与者,随访期间发生 821 例骨折。意向治疗分析显示,盐替代品组与常规盐组在所有骨折(发生率比(RR)0.96;95%可信区间(CI)0.81 至 1.14)、椎体骨折(RR 0.82;95%CI 0.53 至 1.26)、非椎体骨折(RR 1.05;95%CI 0.86 至 1.29)或未知或非特定部位骨折(RR 0.80;95%CI 0.54 至 1.18)的发生率方面无差异。

结论

在心血管疾病和骨折风险高的人群中,与常规盐相比,使用盐替代品对骨折发生率没有明显影响。

试验注册

ClinicalTrials.gov,NCT02092090。于 2014 年 3 月 12 日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d6e/11376003/4c86dc275069/12916_2024_3586_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验